Robert Boggs

1.6k total citations
34 papers, 1.2k citations indexed

About

Robert Boggs is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Robert Boggs has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Rheumatology. Recurrent topics in Robert Boggs's work include Psoriasis: Treatment and Pathogenesis (13 papers), Respiratory and Cough-Related Research (8 papers) and Dermatology and Skin Diseases (7 papers). Robert Boggs is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Respiratory and Cough-Related Research (8 papers) and Dermatology and Skin Diseases (7 papers). Robert Boggs collaborates with scholars based in United States, United Kingdom and Germany. Robert Boggs's co-authors include Joanne Fuiman, Majed Khraishi, Frank Behrens, Kim Papp, Philip J. Mease, Diamant Thaçi, Daniel Alvarez, Eustratios Bananis, Dafna D. Gladman and Robert Northington and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and Epidemiology.

In The Last Decade

Robert Boggs

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Boggs United States	16	734	541	288	267	194	34	1.2k
Christian Sieder Germany	21	415 0.6×	293 0.5×	56 0.2×	260 1.0×	294 1.5×	52	1.4k
Brad Schenkel United States	19	996 1.4×	173 0.3×	632 2.2×	569 2.1×	124 0.6×	62	1.9k
Alexandra McFarlane Canada	7	337 0.5×	542 1.0×	131 0.5×	74 0.3×	51 0.3×	11	935
Shiraz R. Gupta United States	15	700 1.0×	151 0.3×	107 0.4×	366 1.4×	67 0.3×	20	1.2k
Michelle Frits United States	20	157 0.2×	1.1k 2.0×	278 1.0×	18 0.1×	279 1.4×	55	1.6k
Laura Shaughnessy United States	11	432 0.6×	212 0.4×	87 0.3×	72 0.3×	191 1.0×	33	959
Miriam Kimel United States	14	145 0.2×	101 0.2×	94 0.3×	106 0.4×	88 0.5×	32	556
Ira Pande United Kingdom	18	150 0.2×	371 0.7×	142 0.5×	19 0.1×	58 0.3×	43	917
Lynne Cherry United Kingdom	11	341 0.5×	196 0.4×	31 0.1×	14 0.1×	249 1.3×	14	1.4k
Holly John United Kingdom	15	107 0.1×	556 1.0×	150 0.5×	11 0.0×	41 0.2×	28	848

Countries citing papers authored by Robert Boggs

Since Specialization

Citations

This map shows the geographic impact of Robert Boggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Boggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Boggs more than expected).

Fields of papers citing papers by Robert Boggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Boggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Boggs. The network helps show where Robert Boggs may publish in the future.

Co-authorship network of co-authors of Robert Boggs

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Boggs. A scholar is included among the top collaborators of Robert Boggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Boggs. Robert Boggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Domínguez‐Ortega, Javier, J. Christian Virchow, Laurent Guilleminault, et al.. (2025). Prevalence and burden of possible refractory chronic cough in four European countries. ERJ Open Research. 11(4). 888–2024.

Meltzer, Eli O., Robert S. Zeiger, Peter V. Dicpinigaitis, et al.. (2021). Prevalence and Burden of Chronic Cough in the United States. The Journal of Allergy and Clinical Immunology In Practice. 9(11). 4037–4044.e2. 65 indexed citations

Lautsch, Dominik, Robert Boggs, Tongtong Wang, et al.. (2021). Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey. Advances in Therapy. 39(2). 1016–1032. 16 indexed citations

Weiss, Tracey, Richard D. Carr, Lingfeng Yang, et al.. (2020). <p>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</p>. Patient Preference and Adherence. Volume 14. 2337–2345. 74 indexed citations

Meltzer, Eli O., Peter V. Dicpinigaitis, Robert S. Zeiger, et al.. (2020). Chronic Cough in America: Descriptive Analyses of Cough Characteristics and Diagnostic History. Journal of Allergy and Clinical Immunology. 145(2). AB209–AB209. 3 indexed citations

Ke, Xuehua, et al.. (2015). A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings. Clinical Therapeutics. 37(12). 2852–2863. 12 indexed citations

Boggs, Robert, Sarolta Kárpáti, Wenzhi Li, et al.. (2014). Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment. BMC Dermatology. 14(1). 14–14. 13 indexed citations

Mrowietz, Ulrich, Edgardo Chouela, Lotus Mallbris, et al.. (2014). Pruritus and quality of life in moderate‐to‐severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. Journal of the European Academy of Dermatology and Venereology. 29(6). 1114–1120. 65 indexed citations

Kirkham, Bruce, et al.. (2013). The Importance Of Managing Arthritis In Patients With Both Moderate-To-Severe Psoriasis And Psoriatic Arthritis. Value in Health. 16(3). A227–A227. 1 indexed citations

10.

Mease, Philip J., Dafna D. Gladman, Kim Papp, et al.. (2013). Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. Journal of the American Academy of Dermatology. 69(5). 729–735. 375 indexed citations

11.

Christophers, Enno, Siegfried Segaert, Gary Milligan, C. Molta, & Robert Boggs. (2012). Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. Journal of Dermatological Treatment. 24(3). 193–198. 34 indexed citations

12.

Knight, C, Josephine Mauskopf, Mats Ekelund, et al.. (2011). Cost-effectiveness of treatment with etanercept for psoriasis in Sweden. The European Journal of Health Economics. 13(2). 145–156. 15 indexed citations

13.

Gniadecki, Robert, Deborah Robertson, C. Molta, et al.. (2011). Self‐reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. Journal of the European Academy of Dermatology and Venereology. 26(11). 1436–1443. 59 indexed citations

14.

Reich, Kristian, Siegfried Segaert, Peter van de Kerkhof, et al.. (2009). Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology. 219(3). 239–249. 50 indexed citations

15.

Christophers, Enno, Juliet N. Barker, C.E.M. Griffiths, et al.. (2009). The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. Journal of the European Academy of Dermatology and Venereology. 24(5). 548–554. 136 indexed citations

16.

Kaiser, Harold B., Bhash Parasuraman, Robert Boggs, et al.. (2008). Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Annals of Allergy Asthma & Immunology. 101(3). 295–303. 15 indexed citations

17.

Chervinsky, Paul, James Baker, George Bensch, et al.. (2008). Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Annals of Allergy Asthma & Immunology. 101(5). 463–473. 14 indexed citations

18.

Leidy, Nancy Kline, Donald L. Patrick, Robert Boggs, Bhash Parasuraman, & L. O'Dowd. (2007). Perceived Onset of Effect of Budesonide and Formoterol Administered via One Pressurized Metered-dose Inhaler in Patients With Asthma Previously Receiving Inhaled Corticosteroids. Journal of Allergy and Clinical Immunology. 119(1). S246–S247. 2 indexed citations

19.

Nelson, Harold S., et al.. (2007). Budesonide and Formoterol in One Metered-Dose Inhaler Improves Health-Related Quality of Life in Adults with Mild to Moderate Persistent Asthma Previously Treated with Inhaled Corticosteroids. Journal of Allergy and Clinical Immunology. 119(1). S246–S246. 1 indexed citations

20.

Putte, Leo van de, et al.. (2002). UT6 IMPROVEMENT IN HEALTH UTILITY AMONG RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH ADALIMUMAB (D2E7), A FULLY HUMAN ANTI-TNF MONOCLONAL ANTIBODY. Value in Health. 5(6). 461–461. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact